Jupiter Neurosciences cuts quorum to one-third
Jupiter Neurosciences, Inc. lowered its stockholder meeting quorum requirement to one-third of voting power, effective upon board approval.
Rhea-AI Filing Summary
JUPITER NEUROSCIENCES, INC. (JUNS) reports that on August 28, 2026, its Board of Directors approved an amendment to the company’s Amended and Restated Bylaws. The amendment changes the stockholder meeting quorum requirement so that holders of one-third (1/3) of the voting power, present in person or by proxy, now constitute a quorum.
The amendment became effective upon adoption by the Board and is described as Amendment No. 1 to the Amended and Restated Bylaws, which is filed as Exhibit 3.1 and incorporated by reference.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Quorum voting power: One-third (1/3)
Bylaw amendment date: August 28, 2026
Exhibit number for amendment: Exhibit 3.1
3 metrics
Quorum voting power
One-third (1/3)
Voting power required to constitute a quorum at stockholder meetings after the August 28, 2026 bylaw amendment
Bylaw amendment date
August 28, 2026
Date the Board of Directors approved Amendment No. 1 to the Amended and Restated Bylaws
Exhibit number for amendment
Exhibit 3.1
Filed exhibit containing the full text of Amendment No. 1 to the Amended and Restated Bylaws
Key Terms
quorum, Amended and Restated Bylaws, Emerging Growth Company, Nasdaq Capital Market
4 terms
quorum regulatory
"to the quorum requirement to provide that holders of one-third (1/3)"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
Amended and Restated Bylaws regulatory
"approved an amendment to the Company’s Amended and Restated Bylaws"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
Emerging Growth Company regulatory
"Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging Growth Company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Nasdaq Capital Market market
"Common Stock | JUNS | Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
FAQ
What corporate change did JUNS disclose in this 8-K?
Jupiter Neurosciences, Inc. disclosed a bylaw amendment approved on August 28, 2026, changing the stockholder meeting quorum requirement so that holders of one-third (1/3) of the voting power, present in person or by proxy, now constitute a quorum.
How did JUNS change its quorum requirement for stockholder meetings?
Jupiter Neurosciences, Inc. amended its bylaws so that a quorum at a stockholder meeting is now met when holders of one-third (1/3) of the voting power are present, in person or represented by proxy, rather than a higher threshold.
When did the JUNS bylaw amendment on quorum become effective?
The bylaw amendment changing Jupiter Neurosciences, Inc.’s quorum requirement became effective upon adoption by the Board of Directors on August 28, 2026, as stated in the filing.
Where can investors see the full text of JUNS’s quorum amendment?
The full text of the bylaw change is filed as Exhibit 3.1, titled “Amendment No. 1 to Amended and Restated Bylaws,” and is incorporated by reference in the report.
Which securities of JUNS are listed and on what market?
Jupiter Neurosciences, Inc.’s Common Stock trades under the symbol JUNS on the Nasdaq Capital Market, as stated in the securities registration section.
AI-generated analysis. How Rhea-AI works. Not financial advice.
